Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Krishnan Nandabalan | M | 61 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 3 jaar |
Mark H. Pavao | M | - |
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology R-Pharm US LLC engages in development and commercialization of medicines to treat cancer. Its products include IXEMPRA and episil. The company was founded by Mark Pavao and Demetrios Kydonieus in 2014 and is headquartered in Princeton, NJ. | 10 jaar |
Kerrie L. Brady | F | 62 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 3 jaar |
Jonathan Zalevsky | M | 49 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 3 jaar |
Jason Fenton | M | 48 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 2 jaar |
Patricia Spera | M | - |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 3 jaar |
Michael Aiello | M | 44 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 3 jaar |
Jignesh Shah | M | - |
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology R-Pharm US LLC engages in development and commercialization of medicines to treat cancer. Its products include IXEMPRA and episil. The company was founded by Mark Pavao and Demetrios Kydonieus in 2014 and is headquartered in Princeton, NJ. | - |
Salvatore Alesci | M | 50 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 2 jaar |
Shunichiro Okada | M | 66 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 2 jaar |
Aman Kant | M | 40 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 3 jaar |
Sheryl Bauer | F | - |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 2 jaar |
Anita Ganjoo | M | - |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 3 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Sandeep Laumas | M | 56 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | - |
Vimal Mehta | M | 63 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | - |
Melissa Epperly | F | 46 |
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology R-Pharm US LLC engages in development and commercialization of medicines to treat cancer. Its products include IXEMPRA and episil. The company was founded by Mark Pavao and Demetrios Kydonieus in 2014 and is headquartered in Princeton, NJ. | 3 jaar |
Christopher Posner | M | 54 |
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology R-Pharm US LLC engages in development and commercialization of medicines to treat cancer. Its products include IXEMPRA and episil. The company was founded by Mark Pavao and Demetrios Kydonieus in 2014 and is headquartered in Princeton, NJ. | 3 jaar |
Adam Drapczuk | M | 48 |
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology R-Pharm US LLC engages in development and commercialization of medicines to treat cancer. Its products include IXEMPRA and episil. The company was founded by Mark Pavao and Demetrios Kydonieus in 2014 and is headquartered in Princeton, NJ. | 4 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 18 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Demetrios Kydonieus
- Persoonlijk netwerk